2017 annual financial data
Viking Therapeutics 2017 Net income growth
Direct answer
Net income growth was -39.68%.
Operating income was -19,070,189 USD and net income was -20,577,665 USD.
Operating cash flow was -14,757,767 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -19,070,189 USD
- Net income
- -20,577,665 USD
- Operating cash flow
- -14,757,767 USD